Most likely the equivalent of an EIND in India. Bu
Post# of 148321
Under the Philippines CSP I would think most likely orders will be in batches of hundreds to thousands of doses.
Remdesivir has nothing to do with leronlimab in India. When I looked at the data from remdesivir trials at the time of approval I said it's an anti-viral that doesn't reduce viral load which makes it useless. It's about time everyone but the U.S. FDA catches up.